New report reveals need for pricing and reimbursement and procurement reforms to ensure patient access and healthcare sustainability

Generic & biosimilar medicines pivotal for… 28 November 2019 The European Commission has identified the use of generic and…
EU Semester Country Specific Recommendations:… 24 May 2018 The European Semester Country Specific Recommendations show that healthcare systems…
Competition policy essential for access to medicines 28 January 2019 Medicines for Europe welcomes the publication of the European Commission…
Medicines for Europe, APOGEN and Fresenius Kabi hold… 14 November 2019 Almost 70% of medicines dispensed in Europe are generic medicines…